|
🐜
|
Mycophenolate Mofetil versus Oral Cyclophosphamide in Scleroderma-related Interstitial Lung Disease: Scleroderma Lung Study II (SLS-II), a double-blind, parallel group, randomised controlled trial
44 auth.
D. P. Tashkin,
Michael D. Roth,
Philip J. Clements,
Daniel E Furst,
D. Khanna,
E. Kleerup,
J. Goldin,
E. Arriola,
E. Volkmann,
S. Kafaja,
R. Silver,
V. Steen,
C. Strange,
R. Wise,
F. Wigley,
...
M. Mayes,
David J. Riley,
S. Hussain,
S. Assassi,
V. Hsu,
B. Patel,
K. Phillips,
F. Martinez,
Jeff rey Golden,
Kari Connolly,
J. Varga,
J. Dematte,
M. Hinchcliff,
A. Fischer,
J. Swigris,
R. Meehan,
A. Theodore,
R. Simms,
S. Volkov,
Dean E. Schraufnagel,
M. Scholand,
T. Frech,
J. Molitor,
K. Highland,
Charles A Read,
Marvin J. Fritzler,
G. H. J. Kim,
C. Tseng,
R. Elashoff
|
9 |
2016 |
9
🐜
|
